FdaApplication
ANDA 211532
Identifiers
- fda_app_no: ANDA211532
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN LTD |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE | DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE | 10MG | TABLET;ORAL |
| DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE | DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE | 5MG | TABLET;ORAL |
2 products